LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cancer trial tests if less surgery is just as good
Disease control Recruiting nowThis study is testing whether less extensive surgery can work as well as standard surgery for patients with advanced head and neck cancer. All participants first receive drug treatment to shrink their tumors. Those who respond well are then randomly assigned to receive either the…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Qunxing Li,MD • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Custom cancer vaccine designed to train your own immune system
Disease control Recruiting nowThis study is testing a new, personalized vaccine designed to teach the body's immune system to recognize and attack a patient's specific cancer. It is being given alongside an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that have spread. The …
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Radiation & immune drug combo aims to shrink tumors before surgery
Disease control Recruiting nowThis study is testing a two-part treatment given before surgery for advanced head and neck cancer. Patients receive low-dose radiation combined with an immunotherapy drug (an anti-PD-1 inhibitor) to try to shrink the tumor. The goal is to see if this approach makes surgery more e…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Xiwei XU • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug joins fight against tough head and neck cancers
Disease control Recruiting nowThis early-stage study is testing whether adding a new oral drug called ipatasertib to the standard treatment of chemotherapy plus radiation is safe and more effective for people with locally advanced head and neck cancer. The main goal is to find the safest and most effective do…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New cancer injection trial offers hope for elderly patients ineligible for standard chemo
Disease control Recruiting nowThis study is testing whether adding a new nanoparticle injection (NBTXR3) to standard radiation therapy works better for controlling advanced head and neck cancer in elderly patients. It is for people aged 60 and older who cannot safely receive the usual platinum-based chemother…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New hope to stop Cancer's return after tough treatment
Disease control Recruiting nowThis large, global study is testing whether a new drug called volrustomig can help keep cancer from growing or spreading in people with advanced head and neck cancer who have just finished a standard course of chemotherapy and radiation. The trial will compare the drug to simply …
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC